This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bakkevold KE et al. (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater—results of a controlled, prospective, randomised multicentre study. Eur J Cancer 29: 698–703
Takada T et al. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95: 1685–1695
Kosuge T et al. (2006) A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Jpn J Clin Oncol 36: 159–165
Neoptolemos JP et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200–1210
Acknowledgements
The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice. The author wishes to thank Dr Franck Bonnetain (Fédération Française de Cancérologie Digestive) for his assistance with statistical analyses.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hammel, P. Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?. Nat Rev Clin Oncol 4, 460–461 (2007). https://doi.org/10.1038/ncponc0884
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0884